Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Clinical Pharmacokinetics
|
January 1, 2017
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients
Christian Radke, Dagmar Horn, Christian Lanckohr, et al.
Plos One
|
July 15, 2016
Correction: Microarray Noninvasive Neuronal Seizure Recordings from Intact Larval Zebrafish
Michaela Meyer, Sameer C Dhamne, Christopher M LaCoursiere, et al.
Clinical Pharmacokinetics
|
September 6, 2023
Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches
Hauke Ruehs, Alexander Solms, Matthias Frei, et al.
Journal of Breath Research
|
April 23, 2011
Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry
Roman Purkhart, Heike Köhler, Elisabeth Liebler-Tenorio, et al.
Brain Research
|
October 20, 2006
Epileptogenic drugs in a model nervous system: electrophysiological effects and incorporation into a phospholipid layer
Ulrich Altrup, Marc Häder, José Luis Hernández Cáceres, et al.
Clinical Pharmacokinetics
|
June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
Jan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
Clinical Pharmacokinetics
|
June 25, 2024
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Achim Fritsch, Michaela Meyer, Robert O Blaustein, et al.
Pediatric Cardiology
|
May 9, 2024
NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure
Walter Schmitt, Christian Diedrich, Taye H Hamza, et al.
Clinical Pharmacokinetics
|
June 4, 2021
Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Hauke Ruehs, Dagmar Klein, Matthias Frei, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2021
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Walter Schmitt, Hauke Rühs, Rolf Burghaus, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Clinical Pharmacokinetics
|
January 1, 2017
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients
Christian Radke, Dagmar Horn, Christian Lanckohr, et al.
Plos One
|
July 15, 2016
Correction: Microarray Noninvasive Neuronal Seizure Recordings from Intact Larval Zebrafish
Michaela Meyer, Sameer C Dhamne, Christopher M LaCoursiere, et al.
Clinical Pharmacokinetics
|
September 6, 2023
Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches
Hauke Ruehs, Alexander Solms, Matthias Frei, et al.
Journal of Breath Research
|
April 23, 2011
Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry
Roman Purkhart, Heike Köhler, Elisabeth Liebler-Tenorio, et al.
Brain Research
|
October 20, 2006
Epileptogenic drugs in a model nervous system: electrophysiological effects and incorporation into a phospholipid layer
Ulrich Altrup, Marc Häder, José Luis Hernández Cáceres, et al.
Clinical Pharmacokinetics
|
June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals
Jan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
Clinical Pharmacokinetics
|
June 25, 2024
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Achim Fritsch, Michaela Meyer, Robert O Blaustein, et al.
Pediatric Cardiology
|
May 9, 2024
NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure
Walter Schmitt, Christian Diedrich, Taye H Hamza, et al.
Clinical Pharmacokinetics
|
June 4, 2021
Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Hauke Ruehs, Dagmar Klein, Matthias Frei, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2021
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Walter Schmitt, Hauke Rühs, Rolf Burghaus, et al.
Page
of 4